Cargando…
Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic
Coronaviruses have led to severe emergencies in the world since the outbreak of SARS CoV in 2002, followed by MERS CoV in 2012. SARS CoV-2, the novel pandemic caused by coronaviruses that began in December 2019 in China has led to a total of 24,066,076 confirmed cases and a death toll of 823,572 as...
Autores principales: | Negi, Meenakshi, Chawla, Pooja A., Faruk, Abdul, Chawla, Viney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513919/ https://www.ncbi.nlm.nih.gov/pubmed/33007742 http://dx.doi.org/10.1016/j.bioorg.2020.104315 |
Ejemplares similares
Ejemplares similares
-
Principles of SARS-CoV-2 glycosylation
por: Chawla, Himanshi, et al.
Publicado: (2022) -
Preparing for the Perpetual Challenges of Pandemics of Coronavirus Infections with Special Focus on SARS-CoV-2
por: Chawla, Sonam, et al.
Publicado: (2020) -
Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro
por: Wang, Xi, et al.
Publicado: (2023) -
A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease
por: Llanes, Alejandro, et al.
Publicado: (2020) -
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)